메뉴 건너뛰기
Journal of the American Dental Association
Volumn 139, Issue 1, 2008, Pages 12-15
Closing in on the puzzle of ONJ

(1)  Glick, Michael a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

EID: 38849175417     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0002     Document Type: Editorial
Times cited : (9)
References (6)
  • 1
    • 38849148975 scopus 로고    scopus 로고
    • Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial
    • Grbic JT, Landesberg R, Lin S-Q, et al. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial. JADA 2008;139(1):32-40.
    • (2008) JADA , vol.139 , Issue.1 , pp. 32-40
    • Grbic, J.T.1    Landesberg, R.2    Lin, S.-Q.3
  • 2
    • 38849086631 scopus 로고    scopus 로고
    • Bisphosphonate use and the risk of adverse jaw outcomes: A medical claims study of 714,217 people
    • Cartsos V, Zhu S, Zavras A. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people. JADA 2008;139(1):23-30.
    • (2008) JADA , vol.139 , Issue.1 , pp. 23-30
    • Cartsos, V.1    Zhu, S.2    Zavras, A.3
  • 3
    • 36549026045 scopus 로고    scopus 로고
    • Osteonecrosis of the jaws and bisphosphonate therapy
    • Ruggiero SL, Drew SJ. Osteonecrosis of the jaws and bisphosphonate therapy. J Dent Res 2007;86(11):1013-21.
    • (2007) J Dent Res , vol.86 , Issue.11 , pp. 1013-1021
    • Ruggiero, S.L.1    Drew, S.J.2
  • 4
    • 36549010158 scopus 로고    scopus 로고
    • Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates
    • Kimmel DB. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 2007; 86(11):1022-33.
    • (2007) J Dent Res , vol.86 , Issue.11 , pp. 1022-1033
    • Kimmel, D.B.1
  • 5
    • 33845497948 scopus 로고    scopus 로고
    • Adjusted mortality after hip fracture: From the cardiovascular health study
    • Robbins JA. Biggs ML. Cauley J. Adjusted mortality after hip fracture: from the cardiovascular health study. J Am Geriatr Soc 2006;54(12):1885-91.
    • (2006) J Am Geriatr Soc , vol.54 , Issue.12 , pp. 1885-1891
    • Robbins, J.A.1    Biggs, M.L.2    Cauley, J.3
  • 6
    • 33845890326 scopus 로고    scopus 로고
    • Effects of continuing or stopping alendronate after 5 years of treatment: The Fracture Intervention Trial Long-term Extension (FLEX) - a randomized trial
    • Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX) - a randomized trial. JAMA 2006;296(24):2927-38.
    • (2006) JAMA , vol.296 , Issue.24 , pp. 2927-2938
    • Black, D.M.1    Schwartz, A.V.2    Ensrud, K.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.